EP2418217
Frumugagndræpir peptíðhemlar JNK boðmiðlunar taugabrautarinnar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.9.2006EP published:
27.1.2016EP application number:
11003985.6
EP translation filed:
9.3.2016Grant published:
15.4.2016EPO information:
European Patent Register
Max expiry date:
11.9.2026Expiry date:
11.9.2019
Title:
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
Timeline
Today
12.9.2006EP application
27.1.2016EP Publication
9.3.2016Translation submitted
15.4.2016Registration published
11.9.2019Expires
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
Inventor
Name:
Bonny, ChristopheAddress:
Lausanne, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2005/009782Date:
12.9.2005Country:
WO
Classification
Categories:
C07K 14/47
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 20.9.2016
Expires: 11.9.2017
Payer: Guðjón Styrkársson, hrl.
Number: 12
Paid: 28.9.2017
Expires: 11.9.2018
Payer: Guðjón Styrkársson, hrl.
Number: 13
Paid: 15.2.2019
Expires: 11.9.2019
Payer: Guðjón Styrkársson, hrl.